| For: | Annunziata S, Pizzuto DA, Caldarella C, Galiandro F, Sadeghi R, Treglia G. Diagnostic accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography in gallbladder cancer: A meta-analysis. World J Gastroenterol 2015; 21(40): 11481-11488 [PMID: 26523112 DOI: 10.3748/wjg.v21.i40.11481] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i40/11481.htm |
| Number | Citing Articles |
| 1 |
Lincoln Pujari, Zarmina Alam, Satyendra Narayan Singh. Evidence Based Handbook on Diagnosis and Staging in Oncology. 2026; doi: 10.1007/978-981-95-9701-7_21
|
| 2 |
Shraddha Patkar, Aditya Kunte, Vikram Chaudhari, Mahesh Goel. Outcomes of incidental versus non‐incidental T2 gallbladder cancer: A single‐institute experience of 425 cases. Journal of Surgical Oncology 2024; 129(4) doi: 10.1002/jso.27562
|
| 3 |
Niharika Bisht, Nishant Lohia, Sankalp Singh, Arti Sarin, Abhishek Mahato, Dharmesh Paliwal, Indranil Sinha, Sharad Bhatnagar. Utility of 18-Flurodeoxyglucose Positron Emission Tomography-Computed Tomography (18FDG PET-CT) in Gallbladder Cancer: Experience from a Tertiary Care Hospital. World Journal of Nuclear Medicine 2023; 22(04) doi: 10.1055/s-0043-1777699
|
| 4 |
José Manuel Ramia, Jose Manuel Garcia Gil, Alba Manuel-Vazquez, Raquel Latorre-Fragua, Antonio Candia, Roberto de la Plaza-Llamas. False positive PET results due to xanthogranulomatous cholecystitis. Gastroenterología y Hepatología (English Edition) 2022; 45(1) doi: 10.1016/j.gastre.2021.12.001
|
| 5 |
Chunmei Guo, Dengsai Peng, Ya Liu, Liming Chen, Zhanwen Huang. The Superiority of 68 Ga-FAPI-04 over 18F-FDG in a Case of Gallbladder Cancer. Nuclear Medicine and Molecular Imaging 2022; 56(5) doi: 10.1007/s13139-022-00763-5
|
| 6 |
Motokazu Sato, Yusuke Kurita, Eiji Sakai, Seitaro Watanabe, Haruto Sanada, Tomoki Shimizu, Kenji Kanoshima, Yusuke Takai, Koki Meguro, Yuichi Sugimoto, Yusuke Biwata, Kunihiro Hosono, Noritoshi Kobayashi, Kensuke Kubota, Atsushi Nakajima. Computed diffusion-weighted magnetic resonance imaging with high b-values in the diagnosis of gallbladder lesions. Abdominal Radiology 2022; 47(9) doi: 10.1007/s00261-022-03586-2
|
| 7 |
Aditya Kunte, Shraddha Patkar, Vikram Chaudhari, Mahesh Goel. Role of Peri-operative Chemotherapy in Stage II (pT2N0) Gallbladder Cancers. Journal of Gastrointestinal Surgery 2023; 27(1) doi: 10.1007/s11605-022-05495-7
|
| 8 |
Farshad Moradi, Andrei Iagaru. The Role of Positron Emission Tomography in Pancreatic Cancer and Gallbladder Cancer. Seminars in Nuclear Medicine 2020; 50(5) doi: 10.1053/j.semnuclmed.2020.04.002
|
| 9 |
Alireza Rezaee, Rathan M. Subramaniam, Markus Raderer, Werner Langsteger, Mohsen Beheshti. PET/CT in Cancer: An Interdisciplinary Approach to Individualized Imaging. 2018; doi: 10.1016/B978-0-323-48567-8.00007-9
|
| 10 |
Shaifali Goel, Abhishek Aggarwal, Asif Iqbal, Manoj Gupta, Avinash Rao, Shivendra Singh. 18-FDG PET-CT should be included in preoperative staging of gall bladder cancer. European Journal of Surgical Oncology 2020; 46(9) doi: 10.1016/j.ejso.2020.04.015
|
| 11 |
Deepanksha Datta, Prateek Bisht, YT Yogananda, Rajesh Kumar. Physiological Intraluminal Uptake of 18F FDG in Gallbladder on PET/CT – A Retrospective Cohort study in North India. Indian Journal of Nuclear Medicine 2025; 40(4) doi: 10.4103/ijnm.ijnm_31_25
|
| 12 |
Aida Sabaté-Llobera, Gabriel Reynés-Llompart, Judit Mestres-Martí, Laura Gràcia-Sánchez, Laura Lladó, Teresa Serrano, Emilio Ramos, Montserrat Cortés-Romera. Imaging Gallbladder Lesions: What Can Positron Emission Tomography/Computed Tomography Add to the Conventional Imaging Approach?. Journal of Computer Assisted Tomography 2023; 47(3) doi: 10.1097/RCT.0000000000001431
|
| 13 |
Angela Lamarca, Jorge Barriuso, Amarjot Chander, Mairéad G McNamara, Richard A Hubner, Derek ÓReilly, Prakash Manoharan, Juan W Valle. 18F-fluorodeoxyglucose positron emission tomography (18FDG-PET) for patients with biliary tract cancer: Systematic review and meta-analysis. Journal of Hepatology 2019; 71(1) doi: 10.1016/j.jhep.2019.01.038
|
| 14 |
Marc-Anthony Chouillard, Elie K. Chouillard, Andrew A. Gumbs. Gallbladder Cancer. 2023; doi: 10.1007/978-981-19-6442-8_6
|
| 15 |
Archi Agrawal, Nilendu Purandare, Sneha Shah, Ameya Puranik, Venkatesh Rangarajan. PET/CT in Hepatobiliary and Pancreatic Malignancies. 2018; doi: 10.1007/978-3-319-60507-4_8
|
| 16 |
|
| 17 |
Deborah Pencharz, Malavika Nathan, Thomas L Wagner. Evidence-based management of incidental focal uptake of fluorodeoxyglucose on PET-CT. The British Journal of Radiology 2018; 91(1084) doi: 10.1259/bjr.20170774
|
| 18 |
Pratyaksha Rana, Daneshwari Kalage, Raghuraman Soundararajan, Pankaj Gupta. Update on the Role of Imaging in the Diagnosis, Staging, and Prognostication of Gallbladder Cancer. Indian Journal of Radiology and Imaging 2025; 35(02) doi: 10.1055/s-0044-1789243
|
| 19 |
Girish Kumar Parida, Raj Abhisek Panda, Kanhaiyalal Agrawal. Impact of fluorine-18-fluorodeoxyglucose PET/computed tomography in staging of patients with gallbladder cancer: a systematic review and meta-analysis. Nuclear Medicine Communications 2021; 42(8) doi: 10.1097/MNM.0000000000001405
|
| 20 |
Salvatore Annunziata, Daniele Antonio Pizzuto, Federica Galiandro. Evidence-based Positron Emission Tomography. 2020; doi: 10.1007/978-3-030-47701-1_7
|
| 21 |
Vikram Chaudhari, Manish Bhandare, Shailesh V. Shrikhande. Surgical Diseases of the Pancreas and Biliary Tree. 2018; doi: 10.1007/978-981-10-8755-4_15
|
| 22 |
K Søreide, R V Guest, E M Harrison, T J Kendall, O J Garden, S J Wigmore. Systematic review of management of incidental gallbladder cancer after cholecystectomy. Journal of British Surgery 2019; 106(1) doi: 10.1002/bjs.11035
|
| 23 |
L.-T. Chen, A. Vogel, C. Hsu, M.-H. Chen, W. Fang, E.A. Pangarsa, A. Sharma, M. Ikeda, J.O. Park, C.K. Tan, E. Regala, D. Tai, S. Tanasanvimon, C. Charoentum, C.E. Chee, A. Lui, J. Sow, D.-Y. Oh, M. Ueno, A. Ramaswamy, W.S. Jeo, J. Zhou, G. Curigliano, T. Yoshino, L.-Y. Bai, G. Pentheroudakis, N.-J. Chiang, A. Cervantes, J.-S. Chen, M. Ducreux. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with biliary tract cancer. ESMO Open 2024; 9(8) doi: 10.1016/j.esmoop.2024.103647
|
| 24 |
Motoki Nishimura, Nagara Tamaki, Shigenori Matsushima, Kei Yamada. Diseases of the Gallbladder. 2020; doi: 10.1007/978-981-15-6010-1_18
|
| 25 |
Aditya Luhung, Aliya Hasanah, Danni Ramdhani. Radiopharmaceutical: An Update and Comparison of Preclinical Investigation Result of Alpha and Beta Emitter Radioisotope. Drug Design, Development and Therapy 2026; doi: 10.2147/DDDT.S570831
|
| 26 |
Shraddha Patkar, Aditi Chaturvedi, Mahesh Goel, Venkatesh Rangarajan, Ashutosh Sharma, Reena Engineer. Role of positron emission tomography‐contrast enhanced computed tomography in locally advanced gallbladder cancer. Journal of Hepato-Biliary-Pancreatic Sciences 2020; 27(4) doi: 10.1002/jhbp.712
|
| 27 |
Gopinath Gnanasegaran, Kanhaiyalal Agrawal, Simon Wan. 18F-Fluorodeoxyglucose-PET-Computerized Tomography and non-Fluorodeoxyglucose PET-Computerized Tomography in Hepatobiliary and Pancreatic Malignancies. PET Clinics 2022; 17(3) doi: 10.1016/j.cpet.2022.03.007
|
| 28 |
Xiaoping Yin, Zhiyan Lu, Wanjun Xia, Yongmei Li, Liping Liu, Yu Zhang, Liyong Zhuo, Yufang Zhao, Jianing Wang, Lihong Xing, Xinjiang Liu, Xi Ma. Radiology of Hepatobiliary Diseases. 2025; doi: 10.1007/978-981-97-2985-2_64
|
| 29 |
Vikram A. Chaudhari, Manish S. Bhandare, Shailesh V. Shrikhande. Incidental Gallbladder Cancer—Current Recommendations and Management Protocols. Indian Journal of Surgery 2021; 83(S4) doi: 10.1007/s12262-021-02828-9
|
| 30 |
Prakash Singh, Manish Ora, Vineet Mishra, Yogita Khandelwal, Krishna Kant Bharadwaj. Prognostic Utility of Metabolic Parameters and Tumour Markers in Treatment-Naïve Gallbladder Cancer: A Radiometabolic Analysis.. Indian Journal of Nuclear Medicine 2026; 41 doi: 10.25259/IJNM_151_25
|
| 31 |
Can Li, Xiaohui Luan, Xiao Bi, Shengxin Chen, Yue Pan, Jingfeng Zhang, Yun Han, Xiaodan Xu, Guanyun Wang, Baixuan Xu. Multiparameter diagnostic model based on 18F-FDG PET metabolic parameters and clinical variables can differentiate nonmetastatic gallbladder cancer and cholecystitis. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-10599-7
|
| 32 |
Masatoyo Nakajo, Daisuke Hirahara, Megumi Jinguji, Tetsuya Idichi, Mitsuho Hirahara, Atsushi Tani, Koji Takumi, Kiyohisa Kamimura, Takao Ohtsuka, Takashi Yoshiura. Machine learning-based prognostic modeling in gallbladder cancer using clinical data and pre-treatment [18F]-FDG-PET-radiomic features. Japanese Journal of Radiology 2025; 43(5) doi: 10.1007/s11604-024-01722-0
|
| 33 |
Vikas Gupta, K. S. Vishnu, Thakur D. Yadav, Yashwant R. Sakaray, Santosh Irrinki, B. R. Mittal, N. Kalra, K. Vaiphei. Radio-pathological Correlation of 18F-FDG PET in Characterizing Gallbladder Wall Thickening. Journal of Gastrointestinal Cancer 2019; 50(4) doi: 10.1007/s12029-018-0176-2
|
| 34 |
Georgios D. Koimtzis, Christopher G. Chalklin, Eliot Carrington-Windo, Mark Ramsden, Leandros Stefanopoulos, Christoforos S. Kosmidis. The Role of Fine Needle Aspiration Cytology in the Diagnosis of Gallbladder Cancer: A Systematic Review. Diagnostics 2021; 11(8) doi: 10.3390/diagnostics11081427
|
| 35 |
Barkha Pal, Varun Singh Dhull, Vikram R Lele, Girish Vaswani, Neha Balkrishna Rathodkar. 68Ga-FAPI PET/CT Outperforms FDG PET/CT in the Early Detection of the Carcinoma Gall Bladder. Indian Journal of Nuclear Medicine 2026; 0 doi: 10.25259/IJNM_127_25
|
| 36 |
Esra Arslan, Tevfik Fikret Çermik. PET/CT Variants and Pitfalls in Liver, Biliary Tract, Gallbladder and Pancreas. Seminars in Nuclear Medicine 2021; 51(5) doi: 10.1053/j.semnuclmed.2021.04.006
|
| 37 |
焕清 李. Progress in Early Diagnosis of Primary Gallbladder Cancer. Advances in Clinical Medicine 2022; 12(10) doi: 10.12677/ACM.2022.12101348
|
| 38 |
Margarita Kirienko, Fabrizia Gelardi, Francesco Fiz, Matteo Bauckneht, Gaia Ninatti, Cristiano Pini, Alberto Briganti, Massimo Falconi, Wim J. G. Oyen, Winette T. A. van der Graaf, Martina Sollini. Personalised PET imaging in oncology: an umbrella review of meta-analyses to guide the appropriate radiopharmaceutical choice and indication. European Journal of Nuclear Medicine and Molecular Imaging 2024; 52(1) doi: 10.1007/s00259-024-06882-9
|
| 39 |
Senthil Raja, Hian Liang Huang, Cindy Leung, Gopinath Gnanasegaran. Question and Answers in PET/CT. 2026; doi: 10.1007/978-3-032-00821-3_10
|
| 40 |
José Manuel Ramia, Jose Manuel Garcia Gil, Alba Manuel-Vazquez, Raquel Latorre-Fragua, Antonio Candia, Roberto de la Plaza-Llamas. Colecistitis xantogranulomatosa como causa de falso positivo en PET. Gastroenterología y Hepatología 2022; 45(1) doi: 10.1016/j.gastrohep.2020.08.011
|
| 41 |
Miho Akabane, Jun Kawashima, Abdullah Altaf, Selamawit Woldesenbet, Federico Aucejo, Minoru Kitago, Yuki Imaoka, Andrea Ruzzenente, Itaru Endo, Hugo P. Marques, Vincent Lam, Shishir K. Maithel, Tom Hugh, Nazim Bhimani, Timothy M. Pawlik. Preoperative diagnostic failure in gallbladder cancer: Influence of tumor location and size on imaging precision. European Journal of Surgical Oncology 2025; 51(7) doi: 10.1016/j.ejso.2025.109979
|
| 42 |
Dhakshinamoorthy Ganeshan, Avinash Kambadakone, Paul Nikolaidis, Vivek Subbiah, Ishwaria M. Subbiah, Catherine Devine. Current update on gallbladder carcinoma. Abdominal Radiology 2021; 46(6) doi: 10.1007/s00261-020-02871-2
|
| 43 |
Laura Hickman, Carlo Contreras. Gallbladder Cancer. Surgical Clinics of North America 2019; 99(2) doi: 10.1016/j.suc.2018.12.008
|
| 44 |
Dikhra Khan, Rakesh Kumar, Nilendu Purandare. Radiation Oncology – Principles, Precepts and Practice. 2025; doi: 10.1007/978-981-97-8389-2_27
|
| 45 |
Jia-Xin Yin, Xin Fan, Qiao-Liang Chen, Jing Chen, Jian He. Progress in the application of fludeoxyglucose positron emission tomography computed tomography in biliary tract cancer. World Journal of Hepatology 2025; 17(5): 105446 doi: 10.4254/wjh.v17.i5.105446
|
| 46 |
Núria Lluís, Domenech Asbun, Eduardo A. Vega. The SAGES Manual of Contemporary Indications and Management of Hepatic and Biliary Diseases. 2025; doi: 10.1007/978-3-032-04823-3_1
|
| 47 |
Hendrien Kuipers, Frederik JH Hoogwater, Gea A Holtman, Anouk van der Hoorn, Marieke T de Boer, Robbert J de Haas. Clinical value of diffusion-weighted MRI for differentiation between benign and malignant gallbladder disease: a systematic review and meta-analysis. Acta Radiologica 2021; 62(8) doi: 10.1177/0284185120950115
|
| 48 |
Yajnadatta Sarangi, Ashok Kumar. Early detection of gallbladder cancer: Current status and future perspectives. World Journal of Clinical Oncology 2025; 16(7): 107781 doi: 10.5306/wjco.v16.i7.107781
|